One of the most critical areas in the digital transformation of healthcare is the medical imaging infrastructure at the heart of diagnostic processes. While 3.6 billion imaging procedures are performed globally each year (WHO), the number of radiologists cannot keep up with this burden; in pathology laboratories, the manual review of tissue slides can take days, even weeks. On top of this, 90% of hospitals still operate with disconnected, outdated systems. A late or missed diagnosis costs not just inefficiency, but human lives. Viseur AI steps in at exactly this point, redefining how clinical systems operate.

When we evaluated Viseur AI and examined their products in depth, it became convincingly clear that they are addressing the right problem with the right approach. The platform is built around three core pillars. On the "Smart Radiology" side, image storage, viewing, and reporting workflows are managed centrally through PACS and DICOM infrastructure. On the "Digital Pathology" side, the entire pathology workflow from case management to secure remote slide review is digitized; browser based access and AI assisted analysis turn cross institutional collaboration into a daily routine. On the "AI Workflow" side, institutions can build, compare, and deploy their own medical imaging models without writing a single line of code, distributing them across institutions through a single integration via the AI Marketplace. Viseur has demonstrated what this unified structure truly means through real world deployments at the hospitals it works with.

Having founders with deep expertise across radiology, pathology, artificial intelligence, and health technology seated at the same table, each having experienced the relevant problems firsthand from within the industry, was one of the first things that stood out to us. Beyond the team, the other key factors supporting our investment decision were the problem's significant global resonance and the platform's ability to fundamentally change how institutions operate, creating a strong moat and high operational dependency. Viseur will use its funding to advance its product infrastructure and AI solutions, support its expansion into global markets, grow its customer base, and accelerate its sales and marketing operations.

We believe Viseur AI will create lasting and transformative value in clinical AI for the healthcare sector, both in Turkey and on a global scale. As APY Ventures, we are proud to stand alongside the team on this journey.